Scribe Therapeutics, Inc. (SCTX)
15.97
+0.49
(+3.17%)
USD |
NASDAQ |
Nov 06, 10:08
Scribe Therapeutics Shareholders Equity (Quarterly) : -44.49M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.49M |
| Date | Value |
|---|---|
| March 31, 2026 | -38.38M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Twist Bioscience Corp. | 445.74M |
| Veracyte, Inc. | 1.433B |
| Cypherpunk Technologies, Inc. | 139.32M |
| Nurix Therapeutics, Inc. | 968.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.93M |
| Total Liabilities (Quarterly) | 102.42M |
| Debt to Equity Ratio | -0.9726 |
| Current Ratio | 0.5731 |